Meropenem versus Ceftazidime-Avibactam versus Ceftazidime-Avibactam with Aztreonam as empiric, first-line treatment of high-risk febrile neutropenia: first report of the CAMerA Trial, an open-labelled, randomized-controlled trial.
Research Square (Research Square)